ZIVO Bioscience, Inc. (ZIVO): History, Ownership, Mission, How It Works & Makes Money

Ever wondered about the journey of a biotech company dedicated to unlocking nature's secrets for better health? ZIVO Bioscience Inc. (ZIVO), with a market cap of $56.4 million as of April 11, 2025, operates in the biotech and agtech sectors, is focused on developing nutritional and therapeutic products derived from natural compounds. But how did they get here, who steers the ship, and what's their master plan? Keep reading to discover the fascinating story behind ZIVO Bioscience, from its humble beginnings to its ambitious mission of creating sustainable solutions for human and animal health.

ZIVO Bioscience, Inc. (ZIVO) History

Founding Timeline

Year established

The company was originally incorporated in Nevada on December 16, 2005, under the name 'M3 Technology, Inc.' and later reincorporated in Delaware on August 3, 2007. On December 15, 2008, they changed their name to 'ZIVO Bioscience, Inc.'

Original location

The original location of incorporation was Nevada, with later reincorporation in Delaware. The company's headquarters are located in Keego Harbor, Michigan.

Founding team members

Details on the specific founding team members are not available in the provided search results. However, the company has had several key executives and board members throughout its history. As of the latest information, Hayden S. Reynolds serves as the Chief Executive Officer, and John P. Payne is the Chairman of the Board.

Initial capital/funding

Specific details regarding the initial capital or funding at the time of incorporation are not available in the provided search results.

Evolution Milestones

Transformative Moments

• Strategic Shift to Bioscience: The decision to change the company name to ZIVO Bioscience, Inc. in 2008 was a transformative moment, signaling a complete change in business direction.
• Focus on Algal Technology: The research collaboration with Michigan State University (MSU) marked a pivotal shift towards leveraging algal extracts for nutritional and health applications.
• Intellectual Property Development: The filing of provisional patent applications to protect their innovations was crucial for securing their market position and attracting potential investors.
• Animal Feeding Trials: Positive results from animal feeding trials provided critical validation of their technology and opened doors for commercial applications in animal nutrition.

For insights into the company's financial standing, see: Breaking Down ZIVO Bioscience, Inc. (ZIVO) Financial Health: Key Insights for Investors

ZIVO Bioscience, Inc. (ZIVO) Ownership Structure

ZIVO Bioscience, Inc. operates as a publicly traded company, which means its ownership is distributed among public shareholders, institutional investors, and company insiders.

ZIVO Bioscience, Inc.'s Current Status

ZIVO Bioscience, Inc. is a public company, trading on the stock market under the ticker symbol ZIVO. This allows anyone to purchase shares and become a part-owner of the company.

ZIVO Bioscience, Inc.'s Ownership Breakdown

Understanding the ownership structure of ZIVO Bioscience provides insights into who has influence over the company's decisions. As a publicly traded company, the ownership is distributed among various shareholders. The following table illustrates a general overview of the ownership breakdown:

ZIVO Bioscience, Inc.'s Leadership

The leadership team is responsible for the strategic direction and day-to-day operations of ZIVO Bioscience. Key members of the leadership team as of April 2025 include:

• John P. Payne: Chief Executive Officer
• Aric Stone: Chief Financial Officer

For more insights into the company's goals, see: Mission Statement, Vision, & Core Values of ZIVO Bioscience, Inc. (ZIVO).

ZIVO Bioscience, Inc. (ZIVO) Mission and Values

ZIVO Bioscience, Inc. is dedicated to improving human and animal health through the research, development, and commercialization of algal-based bioactive compounds. The company aims to provide innovative solutions for nutrition and health challenges.

ZIVO Bioscience's Core Purpose

Official mission statement

ZIVO Bioscience, Inc. does not have a formal, published mission statement readily available in its recent filings or website content. However, information suggests the company is dedicated to:

• Developing algal-based bioactive compounds for applications in human and animal health.
• Focusing on nutritional and health challenges through innovative solutions.

Vision statement

While a specific vision statement isn't formally declared, ZIVO Bioscience's actions and communications suggest a vision focused on:

• Becoming a leader in the development of algae-derived compounds for health and nutrition.
• Creating sustainable and scalable solutions that address significant health issues.
• Expanding the applications of their unique algal strains to new markets and products.

Company slogan/tagline

There is no official slogan or tagline publicly available for ZIVO Bioscience, Inc. However, considering their activities, a fitting tagline might highlight their focus on algal innovation for health solutions.

To gain more insight into ZIVO Bioscience, Inc., consider reading: Exploring ZIVO Bioscience, Inc. (ZIVO) Investor Profile: Who’s Buying and Why?

ZIVO Bioscience, Inc. (ZIVO) How It Works

ZIVO Bioscience, Inc. operates as a biotechnology company focused on developing and commercializing nutritional feed ingredients and human health applications derived from microalgae.

ZIVO Bioscience, Inc.'s Product/Service Portfolio

ZIVO Bioscience, Inc.'s Operational Framework

ZIVO Bioscience, Inc. focuses on the research, development, and commercialization of microalgae-derived products. Their operational framework includes:

• Strain Development: Identifying and optimizing specific strains of microalgae with desirable characteristics for targeted applications.
• Cultivation and Production: Employing advanced cultivation techniques to grow microalgae efficiently and sustainably.
• Extraction and Processing: Developing proprietary methods to extract and process valuable compounds from microalgae biomass.
• Product Formulation: Formulating extracted compounds into finished products for animal feed, nutraceutical, and dietary supplement markets.
• Clinical Studies: Conducting clinical trials to evaluate the safety and efficacy of their products for human health applications.

ZIVO Bioscience, Inc.'s Strategic Advantages

ZIVO Bioscience, Inc. possesses several strategic advantages that enable market success:

• Proprietary Technology: Owning exclusive rights to innovative microalgae cultivation and extraction technologies.
• Sustainable Production: Utilizing environmentally friendly and sustainable production practices.
• Diverse Product Portfolio: Targeting multiple high-growth markets, including animal health and human nutrition.
• Strategic Partnerships: Collaborating with leading industry players to accelerate product development and commercialization.

To learn more about the investors, read this related article: Exploring ZIVO Bioscience, Inc. (ZIVO) Investor Profile: Who’s Buying and Why?

ZIVO Bioscience, Inc. (ZIVO) How It Makes Money

ZIVO Bioscience, Inc. primarily makes money through the research, development, and commercialization of microalgae-based products, particularly focusing on applications in animal and human health.

ZIVO Bioscience, Inc.'s Revenue Breakdown

As a development-stage company, ZIVO Bioscience, Inc.'s revenue streams are still evolving. Detailed percentage breakdowns for specific revenue streams are not yet available as of April 2025, reflecting its focus on R&D and pre-commercialization activities. However, potential future revenue streams can be inferred from their business activities.

ZIVO Bioscience, Inc.'s Business Economics

ZIVO Bioscience, Inc.'s business economics are characterized by:

• Proprietary Technology: The company leverages its proprietary microalgae platform to develop unique compounds.
• Focus on High-Value Markets: Targeting animal and human health markets allows for potential high-margin product sales upon commercialization.
• Strategic Partnerships: Collaborations can provide funding and expertise, accelerating development timelines.
• Intellectual Property: Patents and trade secrets protect their innovations, creating a competitive advantage.

These elements are designed to support long-term value creation, although profitability is dependent on successful product development and market entry.

ZIVO Bioscience, Inc.'s Financial Performance

As of April 2025, ZIVO Bioscience, Inc.'s financial performance reflects its status as a development-stage company:

• R&D Spending: A significant portion of expenses is allocated to research and development.
• Cash Runway: Monitoring cash reserves is crucial to fund ongoing operations and research activities.
• Funding Sources: The company relies on a mix of equity financing and potential grants to support its activities.
• Pre-Revenue Stage: Financial metrics are focused on managing expenses and securing funding for future growth.

For more insights into the company's investor profile, consider reading: Exploring ZIVO Bioscience, Inc. (ZIVO) Investor Profile: Who’s Buying and Why?

ZIVO Bioscience, Inc. (ZIVO) Market Position & Future Outlook

As of April 2025, remains focused on developing and commercializing algae-based nutritional ingredients and bioactive compounds for human and animal health applications. The company's future hinges on successful clinical trials, regulatory approvals, and effective market penetration of its products.

Competitive Landscape

It is difficult to provide precise, up-to-the-minute market share data as of April 2025. Market share can fluctuate based on various factors, including product launches, clinical trial results, and shifts in consumer preferences. However, to provide a general sense of the competitive landscape, a hypothetical table is presented:

Opportunities & Challenges

faces both opportunities and risks that will shape its trajectory in the coming years.

Industry Position

stands as an innovative player within the broader biotechnology and nutritional ingredients industry. Its focus on algae-based solutions provides a unique angle, aligning with the growing trend towards sustainable and natural products.

• Niche Focus: Specializes in high-value bioactive compounds derived from algae, targeting specific health applications.
• Innovation: Employs a proprietary platform for algae cultivation and compound extraction, setting it apart from competitors.
• Partnerships: Actively seeks collaborations to accelerate product development and market access.

To gain a deeper understanding of the company's core principles, explore: Mission Statement, Vision, & Core Values of ZIVO Bioscience, Inc. (ZIVO).